Brief: Targovax Receives FDA Approval

Circio Holding ASA

27/09/2022 06:17

Sept 27 (Reuters) - Targovax ASA  TRVX.OL :
    * RECEIVES APPROVAL TO PROCEED WITH THE ONCOS-102 PHASE 2
MELANOMA
STUDY FROM THE US FDA
    * STUDY IS ON TRACK TO START IN LATE 2022 OR EARLY 2023

Source text for Eikon:  ID:nObiVYdF4a 
Further company coverage:  TRVX.OL 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))